CBOA
GILD icon

Commonwealth Bank of Australia’s Gilead Sciences GILD Stock Holding History

Commonwealth Bank of Australia’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-236,032
Closed -$15.9M – 395
2019
Q2 		$15.9M Sell
236,032
-102,092
-30% -$6.72M 0.15% 96
2019
Q1 		$22M Buy
338,124
+78,797
+30% +$5.24M 0.21% 75
2018
Q4 		$16.2M Sell
259,327
-2,958
-1% -$207K 0.18% 84
2018
Q3 		$20.2M Sell
262,285
-5,262
-2% -$397K 0.2% 88
2018
Q2 		$18.9M Buy
267,547
+7,572
+3% +$535K 0.19% 83
2018
Q1 		$19.6M Sell
259,975
-45,034
-15% -$3.58M 0.21% 82
2017
Q4 		$21.8M Buy
305,009
+20,979
+7% +$1.59M 0.21% 89
2017
Q3 		$23M Buy
284,030
+30,482
+12% +$2.33M 0.22% 88
2017
Q2 		$17.9M Buy
253,548
+40,150
+19% +$2.67M 0.18% 98
2017
Q1 		$14.5M Buy
213,398
+50,661
+31% +$3.56M 0.16% 104
2016
Q4 		$11.7M Buy
162,737
+37,260
+30% +$2.77M 0.14% 113
2016
Q3 		$9.93M Buy
125,477
+22,300
+22% +$1.81M 0.12% 120
2016
Q2 		$8.61M Buy
103,177
+5,591
+6% +$496K 0.1% 129
2016
Q1 		$8.96M Buy
97,586
+35,440
+57% +$3.2M 0.11% 123
2015
Q4 		$6.29M Buy
62,146
+24,347
+64% +$2.53M 0.08% 155
2015
Q3 		$3.71M Buy
37,799
+66
+0.2% +$7.33K 0.05% 212
2015
Q2 		$4.42M Sell
37,733
-3,092
-8% -$338K 0.06% 174
2015
Q1 		$4.01M Sell
40,825
-2,000
-5% -$203K 0.05% 184
2014
Q4 		$4.04M Sell
42,825
-29,537
-41% -$3.05M 0.06% 174
2014
Q3 		$7.7M Sell
72,362
-2,200
-3% -$215K 0.1% 137
2014
Q2 		$6.18M Sell
74,562
-762,295
-91% -$59.3M 0.08% 152
2014
Q1 		$59.3M Buy
836,857
+68,701
+9% +$5.39M 0.38% 68
2013
Q4 		$57.7M Buy
768,156
+94,488
+14% +$6.58M 0.4% 55
2013
Q3 		$42.4M Sell
673,668
-158,600
-19% -$9.48M 0.31% 79
2013
Q2 		$42.7M Buy
+832,268
New +$43.4M 0.32% 79

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commonwealth Bank of Australia's GILD Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 236,032 shares — an estimated $15.9M sold.

Commonwealth Bank of Australia first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $59.3M in Q1 2014. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 236,032 Gilead Sciences shares in Q3 2019, an estimated $15.9M.
  • Commonwealth Bank of Australia first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Gilead Sciences position peaked at $59.3M in Q1 2014.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.